Massive Hemoptysis Management
Massive Hemoptysis Management: Hemoptysis Presentation → Massive Hemoptysis? → Non-Massive Hemoptysis → Treat Underlying Cause.
Interactive Decision Tree
Algorithm Steps
- ▶Start
Hemoptysis Presentation
Patient coughing up blood
- ◆Decision
Massive Hemoptysis?
Quantify and assess severity
- Massive: >100-200mL/24h OR
- Hemodynamic instability
- Respiratory compromise
- Risk of asphyxiation
- Life-threatening: >500mL/24h
- ●Action
Non-Massive Hemoptysis
Outpatient workup if stable
- CXR as initial imaging
- CT chest if CXR abnormal
- Bronchoscopy if recurrent
- Treat underlying cause
- Follow-up arranged
- ✓Outcome
Treat Underlying Cause
Address etiology
- Bronchiectasis: Optimize treatment
- TB: Anti-TB therapy
- Malignancy: Oncology referral
- Aspergilloma: Consider resection
- Pulmonary HTN: Specific therapy
- ⚠Warning
⚠️ Immediate Stabilization
Protect airway, ensure oxygenation
- Large bore IV access x2
- Type and crossmatch
- High-flow oxygen
- Position bleeding side down (if known)
- Reverse anticoagulation if applicable
- ◆Decision
Airway Secure?
Can patient protect airway?
- Alert and protecting airway
- Maintaining oxygenation
- Not drowning in blood
- ●Action
Intubation Required
Secure definitive airway
- Large ETT (≥8.0) for bronchoscopy access
- Consider mainstem intubation to non-bleeding lung
- Consider double-lumen tube if skilled
- Bronchial blocker alternative
- Video laryngoscopy preferred
- ●Action
Localize Bleeding Source
Imaging and bronchoscopy
- CTA chest: Identify source and etiology
- Bronchoscopy: Direct visualization, therapeutic
- 90% of massive hemoptysis from bronchial arteries
- 10% from pulmonary arteries
- ●Action
Bronchoscopic Interventions
Temporizing measures
- Cold saline lavage
- Topical vasoconstrictors (epinephrine 1:20,000)
- Endobronchial tamponade (balloon, Fogarty catheter)
- Oxidized cellulose or fibrin glue
- Electrocautery/laser if available
- ●Action
Bronchial Artery Embolization (BAE)
First-line definitive treatment
- Success rate 70-90% immediate control
- Recurrence 10-30% at 1 year
- Identify ALL abnormal bronchial arteries
- Avoid spinal artery embolization (paralysis risk)
- May need repeat procedures
- ◆Decision
BAE Successful?
Bleeding controlled?
- ●Action
Post-Procedure Management
ICU monitoring
- ICU admission for monitoring
- Treat underlying condition
- Antibiotics if infection
- Antifungal if aspergilloma
- Plan for recurrence
- ●Action
Surgical Intervention
When embolization fails or not possible
- Lobectomy or pneumonectomy
- High mortality in emergency (20-40%)
- Better outcomes in elective/semi-elective
- Consider if: Localized disease, good pulmonary reserve
- Avoid if: Bilateral disease, poor lung function
- ◆Decision
CTA Findings?
Identify vascular source
- Bronchial artery hypertrophy
- Pulmonary artery pseudoaneurysm
- Aortobronchial fistula
- No clear source
- ●Action
Pulmonary Artery Source
Different approach needed
- PA pseudoaneurysm (Rasmussen)
- PAA embolization
- May need coils, plugs
- Higher complexity procedure
Guideline Source
A systematic approach to the management of massive hemoptysis
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Definition of massive hemoptysis varies (100-1000mL/24h)
- Bronchial artery embolization availability varies
- Requires multidisciplinary approach
- Does not cover anticoagulation reversal in detail
Applicable Regions
Global: Interventional radiology and thoracic surgery availability varies
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Pulmonary Embolism Severity Index (PESI)
30-day mortality risk stratification for acute pulmonary embolism
Compare
AttendMe.ai vs DynaMed
See how this pathway workflow compares against DynaMed.
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Related Resources
Frequently Asked Questions
What is the Massive Hemoptysis Management?
The Massive Hemoptysis Management is a emergency clinical algorithm for Pulmonary Medicine. It provides a structured decision tree to guide clinical decision-making, based on A systematic approach to the management of massive hemoptysis.
What guideline is the Massive Hemoptysis Management based on?
This algorithm is based on A systematic approach to the management of massive hemoptysis (DOI: 10.21037/jtd.2017.06.41).
What are the limitations of the Massive Hemoptysis Management?
Known limitations include: Definition of massive hemoptysis varies (100-1000mL/24h); Bronchial artery embolization availability varies; Requires multidisciplinary approach; Does not cover anticoagulation reversal in detail. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Massive Hemoptysis Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free